​

Quest Diagnostics (DGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DGX Stock Forecast

Quest Diagnostics (DGX) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $220.57, with a high of $235.00 and a low of $210.00. This represents a 12.38% increase from the last price of $196.27.

$100 $130 $160 $190 $220 $250 High: $235 Avg: $220.57 Low: $210 Last Closed Price: $196.27

DGX Stock Rating

Quest Diagnostics stock's rating consensus is Hold, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (38.24%), 18 Hold (52.94%), 3 Sell (8.82%), and 0 Strong Sell (0.00%).

Hold
Total 34 0 3 18 13 Strong Sell Sell Hold Buy Strong Buy

DGX Price Target Upside V Benchmarks

TypeNameUpside
StockQuest Diagnostics12.38%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks32.15%

Price Target Trends

1M3M12M
# Anlaysts31023
Avg Price Target$220.00$219.40$207.83
Last Closing Price$196.27$196.27$196.27
Upside/Downside12.09%11.78%5.89%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26278--17
Mar, 26277-117
Feb, 26278-118
Jan, 261710--18
Dec, 25179-118
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 21, 2026Evercore ISI$225.00$205.189.66%14.64%
Apr 21, 2026Jefferies$225.00$205.189.66%14.64%
Apr 08, 2026Evercore ISI$210.00$198.815.63%7.00%
Feb 12, 2026Mizuho Securities$235.00$209.3212.27%19.73%
Feb 11, 2026UBS$210.00$206.731.58%7.00%
Feb 11, 2026Truist Financial$220.00$205.636.99%12.09%
Feb 11, 2026Elizabeth AndersonEvercore ISI$220.00$205.437.09%12.09%
Feb 11, 2026Robert W. Baird$219.00$205.356.65%11.58%
Feb 10, 2026Tycho PetersonJefferies$220.00$205.247.19%12.09%
Jan 30, 2026Barclays$210.00$182.3515.16%7.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 21, 2026JefferiesBuyBuyhold
Feb 11, 2026UBSNeutralNeutralhold
Feb 11, 2026CitigroupNeutralNeutralhold
Feb 10, 2026JefferiesBuyBuyhold
Jan 30, 2026BarclaysEqual-WeightOverweightupgrade
Oct 27, 2025Piper SandlerNeutralNeutralhold
Oct 22, 2025Morgan StanleyOverweightOverweighthold
Oct 21, 2025JefferiesBuyBuyhold
Oct 21, 2025Leerink PartnersOutperformOutperformhold
Oct 17, 2025UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

$7 $8 $9 $10 $11 $12 $13 $14 $15 $16 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.90$8.12$7.59$7.80$8.87---
Avg Forecast$14.12$9.85$8.71$8.90$9.73$10.51$11.56$12.71
High Forecast$14.81$10.03$8.75$8.93$9.77$12.37$12.45$13.00
Low Forecast$13.49$9.53$8.68$8.87$9.70$9.86$10.67$12.13
Surprise %12.61%-17.56%-12.86%-12.36%-8.84%---

Revenue Forecast

$9B $10B $10B $11B $12B $13B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.79B$9.88B$9.25B$9.87B$11.04B---
Avg Forecast$10.74B$9.83B$9.22B$9.83B$10.71B$11.13B$11.68B$12.06B
High Forecast$11.15B$9.97B$9.24B$9.84B$10.84B$11.17B$11.88B$12.27B
Low Forecast$10.37B$9.58B$9.20B$9.81B$10.50B$11.10B$11.49B$11.63B
Surprise %0.44%0.54%0.39%0.43%3.06%---

Net Income Forecast

$500M $900M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.00B$946.00M$854.00M$871.00M$992.00M---
Avg Forecast$1.71B$1.31B$850.00M$1.01B$1.10B$1.26B$1.38B$1.44B
High Forecast$2.06B$1.57B$1.02B$1.01B$1.10B$1.40B$1.41B$1.47B
Low Forecast$1.37B$1.04B$680.00M$1.00B$1.10B$1.11B$1.21B$1.37B
Surprise %16.48%-27.57%0.47%-13.39%-9.80%---

DGX Forecast FAQ

Is Quest Diagnostics stock a buy?

Quest Diagnostics stock has a consensus rating of Hold, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 18 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Quest Diagnostics is a neutral investment for most analysts.

What is Quest Diagnostics's price target?

Quest Diagnostics's price target, set by 34 Wall Street analysts, averages $220.57 over the next 12 months. The price target range spans from $210 at the low end to $235 at the high end, suggesting a potential 12.38% change from the previous closing price of $196.27.

How does Quest Diagnostics stock forecast compare to its benchmarks?

Quest Diagnostics's stock forecast shows a 12.38% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (32.15%).

What is the breakdown of analyst ratings for Quest Diagnostics over the past three months?

  • April 2026: 11.76% Strong Buy, 41.18% Buy, 47.06% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.
  • February 2026: 11.11% Strong Buy, 38.89% Buy, 44.44% Hold, 0% Sell, 5.56% Strong Sell.

What is Quest Diagnostics’s EPS forecast?

Quest Diagnostics's average annual EPS forecast for its fiscal year ending in December 2026 is $10.51, marking a 18.49% increase from the reported $8.87 in 2025. Estimates for the following years are $11.56 in 2027, and $12.71 in 2028.

What is Quest Diagnostics’s revenue forecast?

Quest Diagnostics's average annual revenue forecast for its fiscal year ending in December 2026 is $11.13B, reflecting a 0.87% increase from the reported $11.04B in 2025. The forecast for 2027 is $11.68B, and $12.06B for 2028.

What is Quest Diagnostics’s net income forecast?

Quest Diagnostics's net income forecast for the fiscal year ending in December 2026 stands at $1.26B, representing an 26.63% increase from the reported $992M in 2025. Projections indicate $1.38B in 2027, and $1.44B in 2028.